Rheumatoid arthritis

Predicting rapid radiographic progression in difficult-to-treat rheumatoid arthritis: insights from long-term follow-up

Rheumatology (Oxford)Published Cohort study

Authors' conclusion

In contrast, many D2T RA patients exhibited comparatively slow radiographic progression indicating that many D2T RA cases are at least partially treated.

Study context

Population
EULAR-defined difficult-to-treat RA (D2T RA) patients114 with serial radiographs
Participants
254 participants
Exposure
Persistent inflammatory refractory RA (PIRRA) vs non-inflammatory refractory RA (NIRRA); Poly-refractory RA (pr-RA) vs other D2T RA
  • PIRRAn = 43
  • pr-RAn = 14
Outcome
Long-term radiographic progression (mSvdH units/year); rapid radiographic progression (RRP, ≥5 mSvdH units/year)
Follow-up
Mean 9 years
Methodological detailslong-term follow-up, serial radiographs, multivariable analysis
  • Long-term follow-up
  • Serial radiographs
  • Multivariable analysis

Main finding

As reported in the abstract

Annual mSvdH progression

P = 0.025

Mean annual modified Sharp/van der Heijde (mSvdH) progression, all D2T RA with serial radiographs
2.8 units
Time-integrated CRP associated with significantly greater annual radiographic progression
P < 0.001

Observational data: associations, not effects.

Further findings

Outcomepr-RAOther D2T RAP value
RRP, pr-RA vs other D2T RA (subgroup)50%19.4%P = 0.048

Independent predictors of rapid radiographic progression (RRP) (multivariable analysis)

Older age independently associated with RRP
P = 0.017
Swollen joint count independently associated with RRP
P = 0.009

Original publication

Predicting rapid radiographic progression in difficult-to-treat rheumatoid arthritis: insights from long-term follow-up. Rheumatology (Oxford). Published 1 October 2025. doi:10.1093/rheumatology/keaf515

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.